ORIGINAL RESEARCH article
Front. Immunol.
Sec. NK and Innate Lymphoid Cell Biology
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1607770
This article is part of the Research TopicUnveiling Distinctions: Active Tuberculosis versus Latent Tuberculosis Infection - Immunological Insights, Biomarkers, and Innovative ApproachesView all 12 articles
Transcriptomic and Proteomic Signatures of Host NK Cells Delineate Distinct Immune States Across Tuberculosis Infection Statuses
Provisionally accepted- 1Institute of Pathogen Biology (CAMS), Beijing, Beijing Municipality, China
- 2Beijing Chest Hospital, Capital Medical University, Beijing, Beijing Municipality, China
- 3Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Mycobacterium tuberculosis (M.tb) infection, systematic investigations delineating the immune characteristics of NK cells across the tuberculosis (TB) disease spectrum are scarce. This multiomics study employed transcriptomic, proteomic, and RT-qPCR analyses to characterize and validate CD56+ NK cells from 165 participants stratified by TB infection status (active TB (ATB), latent TB infection (LTBI), and healthy control (HC)). Peripheral blood samples from an independent cohort of 85 participants were subjected to flow cytometry analysis and validation. Enrichment analyses of transcriptomic and proteomic data revealed that the NK cell-mediated cytotoxicity and apoptosis pathways were enriched in LTBI and ATB groups, whereas chemotaxis-related pathway enrichment was specific to ATB. Further analysis revealed that the expression of genes mediating the NK cell-mediated cytotoxicity signaling pathway through perforin-granzyme was upregulated in the LTBI state, whereas that of those associated with death receptors was elevated in ATB, potentially indicating a transformation of NK cell function in different TB infection states.Moreover, analysis of ATB-specific chemotaxis genes suggested that the migration of NK cells was likely to occur in the ATB state. Flow cytometry revealed an increased frequency of CD56dim NK cells and a decreased frequency of CD56bright NK cells in individuals with LTBI versus that in HCs in an independent cohort. In addition, RT-qPCR validation identified a four-biomarker combination (SLC7A5, PDE4D, CXCR4, and SOCS3) distinguishing ATB from HCs, a three-biomarker combination (SLC7A5, PER1, and PDE4D) differentiating LTBI from HC, and a three-biomarker combination (SOCS3, GZMK, and HIST1H3B) differentiating ATB from LTBI. These findings elucidate the immune clearance mechanism of NK cells in TB and provide clinically actionable biomarkers for infection staging, advancing our understanding of TB immunopathogenesis.
Keywords: Tuberculosis, RNA sequencing, liquid chromatography-tandem mass spectrometry, Natural Killer cells, CD56dim NK cell, CD56bright NK cell, Natural killer cell-mediated cytotoxicity, biomarker
Received: 08 Apr 2025; Accepted: 29 May 2025.
Copyright: © 2025 Zhang, Liu, Hu, Wu, Zheng, Xin, Du, Yang, Lv, Wu, Gao, Liu, SUN, ZHANG and Jin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Qi Jin, Institute of Pathogen Biology (CAMS), Beijing, Beijing Municipality, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.